Supplements · Sweeteners
non-nutritive sweeteners increases diabetes risk
Part of: • non-nutritive sweeteners
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Artificially-sweetened-beverage consumption is **consistently associated** with higher type-2-diabetes incidence across large cohorts (and the NutriNet-Santé cohort) — so as an *association* the claim leans supported. **But causation is doubtful:** the signal largely dissolves after adjusting for body weight/adiposity (Imamura, BMJ), points to reverse causation (people at higher metabolic risk swi
The evidence (9)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Drouin-Chartier et al. 2019 · Diabetes Care | observational | supports | moderate | Three large US cohorts: increases in ASB consumption associated with modestly higher subsequent T2D risk (attenuated by BMI). |
| Payen de la Garanderie M 2025 · PLoS Med | observational | supports | moderate | NutriNet-Santé food-additive mixtures (incl. a sweetener/emulsifier cluster) associated with higher T2D incidence. |
| Qin et al. 2020 · Eur J Epidemiol | meta-analysis | supports | moderate | Dose-response MA: ASB associated with higher T2D (and obesity, hypertension). |
| Meng 2021 · Nutrients | meta-analysis | supports | moderate | Dose-response MA: each additional ASB serving/day associated with higher T2D risk. |
| Debras C 2023 · Diabetes Care | observational | supports | moderate | NutriNet-Santé: total artificial sweeteners (esp. aspartame, acesulfame-K) associated with higher type-2-diabetes risk. |
| Greenwood et al. 2014 · Br J Nutr | meta-analysis | mixed | moderate | MA: ASB–T2D association less consistent than SSB and attenuated by BMI adjustment — possible confounding/reverse causation. |
| Imamura et al. 2015 · BMJ | meta-analysis | mixed | high | MA (BMJ): ASB–T2D association substantially attenuated after adjustment for adiposity — largely reflects reverse causation, not a causal effect. |
| Ayoub-Charette et al. 2025 · Appl Physiol Nutr Metab | meta-analysis | contradicts | high | Bias-adjusted cohort analyses: NNS associated with LOWER obesity/diabetes — the naïve 'higher risk' reverses under substitution/bias-adjusted methods. |
| Lohner et al. 2020 · Cochrane Database Syst Rev | meta-analysis | mixed | moderate | Cochrane (NNS in diabetes): insufficient evidence to establish benefit or harm on hard outcomes. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.